Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment.
Rheumatoid arthritis (RA) is a chronic, inflammatory, and autoimmune disease that can cause permanent joint damage. In our study, we aim to analyze the change in calprotectin levels following the low-density exercise levels applied to the patients with RA. Twenty-eight patients with RA and 30 healthy controls were included in this study. To evaluate the activity of disease in RA, scores of disease activity that has increased (DAS-28) are figured. Calprotectin, nitric oxide (NO), white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and rheumatoid factor (RF) levels are tested as the laboratory evaluation. Calprotectin, NO, CRP, ESR, WBC, and RF levels were significantly higher in the patient group compared to the control group (p < 0.01, p < 0.001, p < 0.01, p < 0.01, p < 0.01, and p < 0.05, respectively). In correlation analysis applied to the patient group with RA, there has been determined a positive relation with calprotectin, and DAS-28, CRP, NO, RF, and WBC (p < 0.001, p < 0.05, p < 0.001, p < 0.05, and p < 0.05, respectively). In result of the low-density exercise treatment applied to patients with RA for 8 weeks, there has been determined a significant decrease in calprotectin, DAS-28, NO, CRP, ESR, and RF levels (p < 0.05, p < 0.001, p < 0.01, p < 0.05, p < 0.05, and p < 0.05, respectively). As a result, a significant relation is found between RA disease activity and calprotectin levels and other inflammatory parameters. At the same time, it shows that calprotectin which is a significant indicator of local inflammation can be used as a good identifier in following up exercise treatment.
Department of Medical Biochemistry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Ayse
A
Acar
Department of Medical Biochemistry, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey. savasguzel@yahoo.com.
Savas
S
Guzel
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Banu
B
Sarifakioglu
Department of Family Physician, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Eda Celik
EC
Guzel
Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Namik Kemal University, Tekirdag, Turkey.
Aliye Yildirim
AY
Guzelant
Department of Physical Medicine and Rehabilitation, Tekirdag Government Hospital, Tekirdag, Turkey.
Ceyda
C
Karadag
Electrical and Computer Engineering, Independent Research Associated, Stuttgart, Germany.
Lebriz
L
Kiziler
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood* / Q000175:diagnosis / Q000628:therapy*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D005081:Exercise Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D007958:Leukocyte Count; D039841:Leukocyte L1 Antigen Complex / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000097:blood; D011379:Prognosis; D012217:Rheumatoid Factor / Q000097:blood; D012720:Severity of Illness Index; D016896:Treatment Outcome
D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex; D009569:Nitric Oxide; D002097:C-Reactive Protein; D012217:Rheumatoid Factor
Calprotectin; Disease activity; Exercise treatment; Nitric oxide; Rheumatoid arthritis